Michael Klompas's guest appearances

Michael Klompas

NEJM Interviews

Infection Control Matters

Barack Obama

Cecile Richards

Nicholas Bagley

Scott Burris

Wendy Parmet

John McConnell

David Kessler

Robert Aronowitz

Aaron Kesselheim

Mark Hall

George Church

David Hunter

Vivian Lee

George Annas

John McDonough

OwlTail

In this week's episode, Martin talks to Dr Michael Klompas, Infectious Disease physician, Hospital Epidemiologist, and Professor of Population Medicine at Harvard Medical School and Brigham and Women's Hospital, Boston, USA. We discuss the complexities of undertaking surveillance of Ventilator-associated pneumonia (VAP) and the USA approach to looking at the wider issue of Ventilator-associated Events (VAE) that removes subjectivity from the surveillance of these important complications. We also discuss the recent SHEA/IDSA/APIC/AMA prevention strategies paper that is the latest state of the art guidance on VAP/VAE prevention. Useful reading here: 1. Klompas M, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(6):687-713.  https://doi.org/10.1017/ice.2022.88 2. Weinberger JF, et al. Changes in the epidemiology of ventilator-associated events over the course of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021:1-3. https://doi.org/10.1017/ice.2021.459 3. Klompas M. Ventilator-Associated Events: What They Are and What They Are Not. Respir Care. 2019;64(8):953-961.  https://doi.org/10.4187/respcare.07059 4. Klompas M. Ventilator-associated conditions versus ventilator-associated pneumonia: different by design. Curr Infect Dis Rep. 2014;16(10):430.  https://doi.org/10.1007/s11908-014-0430-0 5. Klompas M, et al. Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis. 2008;46(9):1443-1446.  https://doi.org/10.1086/587103 

In this week's episode, Martin talks to Dr Michael Klompas, Infectious Disease physician, Hospital Epidemiologist, and Professor of Population Medicine at Harvard Medical School and Brigham and Women's Hospital, Boston, USA. We discuss the complexities of undertaking surveillance of Ventilator-associated pneumonia (VAP) and the USA approach to looking at the wider issue of Ventilator-associated Events (VAE) that removes subjectivity from the surveillance of these important complications. We also discuss the recent SHEA/IDSA/APIC/AMA prevention strategies paper that is the latest state of the art guidance on VAP/VAE prevention. Useful reading here: 1. Klompas M, et al. Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update. Infect Control Hosp Epidemiol. 2022;43(6):687-713.  <a href="https://doi.org/10.1017/ice.2022.88" rel="nofollow" target="_blank">https://doi.org/10.1017/ice.2022.88</a> 2. Weinberger JF, et al. Changes in the epidemiology of ventilator-associated events over the course of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021:1-3. <a href="https://doi.org/10.1017/ice.2021.459" rel="nofollow" target="_blank">https://doi.org/10.1017/ice.2021.459</a> 3. Klompas M. Ventilator-Associated Events: What They Are and What They Are Not. Respir Care. 2019;64(8):953-961.  <a href="https://doi.org/10.4187/respcare.07059" rel="nofollow" target="_blank">https://doi.org/10.4187/respcare.07059</a> 4. Klompas M. Ventilator-associated conditions versus ventilator-associated pneumonia: different by design. Curr Infect Dis Rep. 2014;16(10):430.  <a href="https://doi.org/10.1007/s11908-014-0430-0" rel="nofollow" target="_blank">https://doi.org/10.1007/s11908-014-0430-0</a> 5. Klompas M, et al. Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis. 2008;46(9):1443-1446.  <a href="https://doi.org/10.1086/587103" rel="nofollow" target="_blank">https://doi.org/10.1086/587103</a>

VAP in the ’too difficult’ box - could VAE be the answer? with Dr Michael Klompas

Martin Kiernan managaed to grab a few minutes with Dr Michael Klompas, ID Physicial at Brigham and Women's Hospital, Boston and Associate Professor at Harvard Medical School, at the SHEA Spring meeting. We discuss the use of N95 masks and whether in a time of Omicron increased prevalence they should be used in all healthcare settins and not just for suspected or confirmed cases of COVID. Some of Dr Klompas' recent papers are here: 1. Klompas M, et al. Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High. Clin Infect Dis. 2022;74(3):529-531.  doi:10.1093/cid/ciab539 2. Klompas M, et al. Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant. JAMA. 2022;327(7):619-620.  https://jamanetwork.com/journals/jama/article-abstract/2788503 3. Klompas M, et al. COVID-19's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission. Clin Infect Dis. 2022.  https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciac204/6546689 4. Baker MA, et al. Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators. Clin Infect Dis. 2022.  https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac113/6523822 5. Klompas M, et al. Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs : A Narrative Review. Ann Intern Med. https://pubmed.ncbi.nlm.nih.gov/34748374/

Martin Kiernan managaed to grab a few minutes with Dr Michael Klompas, ID Physicial at Brigham and Women's Hospital, Boston and Associate Professor at Harvard Medical School, at the SHEA Spring meeting. We discuss the use of N95 masks and whether in a time of Omicron increased prevalence they should be used in all healthcare settins and not just for suspected or confirmed cases of COVID. Some of Dr Klompas' recent papers are here: 1. Klompas M, et al. Universal Use of N95 Respirators in Healthcare Settings When Community Coronavirus Disease 2019 Rates Are High. Clin Infect Dis. 2022;74(3):529-531.  doi:10.1093/cid/ciab539 2. Klompas M, et al. Preventing SARS-CoV-2 Transmission in Health Care Settings in the Context of the Omicron Variant. JAMA. 2022;327(7):619-620.  <a href="https://jamanetwork.com/journals/jama/article-abstract/2788503" rel="nofollow" target="_blank">https://jamanetwork.com/journals/jama/article-abstract/2788503</a> 3. Klompas M, et al. COVID-19's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission. Clin Infect Dis. 2022.  <a href="https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciac204/6546689" rel="nofollow" target="_blank">https://academic.oup.com/cid/advance-article-abstract/doi/10.1093/cid/ciac204/6546689</a> 4. Baker MA, et al. Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators. Clin Infect Dis. 2022.  <a href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac113/6523822" rel="nofollow" target="_blank">https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciac113/6523822</a> 5. Klompas M, et al. Current Insights Into Respiratory Virus Transmission and Potential Implications for Infection Control Programs : A Narrative Review. Ann Intern Med. <a href="https://pubmed.ncbi.nlm.nih.gov/34748374/" rel="nofollow" target="_blank">https://pubmed.ncbi.nlm.nih.gov/34748374/</a>

N95 Mask use for respiratory protection - a discussion with Dr Michael Klompas at the SHEA Spring Meeting

Dr. Michael Klompas is an Associate Professor of Population Medicine at Harvard Medical School and Harvard Pilgrim Health Care Institute and an infectious disease physician and epidemiologist at Brigham and Women's Hospital. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. C. Rhee, S. Gohil, and M. Klompas. Regulatory Mandates for Sepsis Care - Reasons for Caution. N Engl J Med 2014;370:1673-6.

NEJM Interview: Dr. Michael Klompas on the apparent increase in sepsis rates and the problematic mandates for sepsis care.